Trials / Not Yet Recruiting
Not Yet RecruitingNCT06975462
A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases
SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases: a Prospective，Sigle-arm，Phase II Study
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-arm study to explore the efficacy and safety of SHR-A1811 combined with radiotherapy in patients with HER2-positive or HER2-low brain metastases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | SHR-A1811 and radiotherapy | SHR-A1811:4.8mg/kg radiotherapy: 800cGY\*5 |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-12-01
- First posted
- 2025-05-16
- Last updated
- 2025-05-16
Source: ClinicalTrials.gov record NCT06975462. Inclusion in this directory is not an endorsement.